Switch to:
More From Other Websites
Antares Pharma to Host First Quarter Operating and Financial Results Conference Call May 05 2016
Antares Pharma To Host First Quarter Operating And Financial Results Conference Call May 02 2016
Antares Pharma to Present at the Deutsche Bank Securities,INC 41st Annual Healthcare Conference Apr 27 2016
Antares Pharma to Present at the Deutsche Bank Securities, Inc. 41st Annual Health Care Conference Apr 27 2016
OTREXUP.COM Website Awarded a Bronze Horizon Interactive Award Apr 25 2016
4 Trending Small Cap Stocks Making Big Moves Today Apr 22 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Apr 15 2016
New Strong Sell Stocks for April 6th Apr 06 2016
Antares Pharma Discloses Pen 1 Development Project as Teriparatide Apr 05 2016
Antares Pharma Discloses “Pen 1” Development Project as Teriparatide Apr 05 2016
New Strong Sell Stocks for March 31st Mar 31 2016
Additional Dosage Strengths of Otrexup™ (methotrexate) Injection Approved by FDA Mar 29 2016
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016
Five Penny Stocks To Buy Based on Smart Money Sentiment Mar 26 2016
OraSure Technologies Appoints Eamonn P. Hobbs to its Board of Directors Mar 23 2016
Falling Earnings Estimates Signal Weakness Ahead for Antares Pharma (ATRS) Mar 18 2016
Antares Pharma Announces Completion of the 52 Week QuickShot® Phase 3 Study in Testosterone... Mar 16 2016
ANTARES PHARMA, INC. Financials Mar 12 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Mar 10 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Mar 09 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK